Corporate Overview
Pain Therapeutics, Inc. is a biopharmaceutical company that develops novel drugs. In addition to REMOXY, a unique, abuse-resistant controlled-release oxycodone, the Company has three drug candidates in clinical programs, including a novel radio-labeled monoclonal antibody to treat metastatic melanoma, as well as PTI-202 and PTI-721. Pain Therapeutics is also working on a new treatment for patients with hemophilia.
Pain Therapeutics Stock Information
| Current Price: |
$5.30 |
| Change |
- 1.12%
0.06 |
| Day High |
$5.53 |
| Day Low |
$5.23 |
| Volume |
39,900 |
2:03 PM ET on Jul 29, 2010
Quote delayed at least 20 minutes.
|
|
Recent Releases
Jul 28, 2010
Pain Therapeutics Reports Second Quarter 2010 Financial Results
Jun 28, 2010
Pain Therapeutics Modifies Strategic Alliance for REMOXY(R) in Europe
View all releases »
|
